Adult AD diagnoses were based on the modified Hanifin major criteria of a history of a chronic and relapsing course; pruritus; a pattern of facial and extensor eczema and xerosis at a younger age ...

The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the ...

Jason B. Pieper, DVM, MS, DACVD: …It is tough when we talk about atopic dermatitis, I mean, there's a variety [of causes].

Dermatitis refers to a number of skin conditions driven by inflammation, including atopic dermatitis (a type of eczema) and contact dermatitis. Dermatitis isn’t always curable, but it’s ...

The FDA has granted a fast track designation to rezpegaldesleukin for treating patients aged 12 years and older with moderate ...

Jason B. Pieper, DVM, MS, DACVD, talks about the multiple therapies available for cases of moderate and severe atopic dermatitis and delves into each option ...

Patients with mild atopic dermatitis who reported nighttime scratching experienced relief when they used an artificial ...

Self-guided cognitive behavioral therapy was non-inferior in reducing atopic dermatitis symptom severity as clinician-guided ...

Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...

SAN FRANCISCO - Nektar Therapeutics (NASDAQ:NKTR) announced today that its drug candidate, rezpegaldesleukin, has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ...